Document is current
Any future updates will be listed below
-
Authors
Tippani, Madhavi
Pattie, Elizabeth A.
Davis, Brittany A.
Nguyen, Claudia V.
Wang, Yanhong
Sripathy, Srinidhi Rao
Maher, Brady J.
Martinowich, Keri
Jaffe, Andrew E.
Page, Stephanie Cerceo http://orcid.org/0000-0002-1951-7398
- License Information
-
More Information
Article History
Received: 1 September 2021
Accepted: 2 November 2022
First Online: 30 November 2022
Declarations
:
: <i>Human donors</i> All human fibroblast donors were part of the Sibling Study of Schizophrenia at the National Institutes of Mental Health in the Clinical Brain Disorders Branch (NIMH, protocol 95M0150, NCT00001486, Annual Report number: ZIA MH002942053, DRW PI), as previously described []. All fibroblast samples were obtained after informed consent. <i>Cell Lines:</i> All human cell lines used in this work were generated at the Lieber Institute for Brain Development. Identity has been authenticated by STR testing, and mycoplasma testing was performed monthly. <i>Animals</i> All experimental animal procedures were approved by the SoBran Biosciences Institutional Animal Care and Use Committee.
: Not Applicable.
: Andrew E. Jaffe is now employed by Neumora Therapeutics, a for-profit biotechnology company, which is unrelated to the contents of this manuscript. No other authors have financial relationships with commercial interests, and the authors declare no competing interests.
